Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tumor Cell Lysis via Oncolytic Adenovirus Delivery
- Molecular classification
- Oncolytic Virus, Gene Therapy, Cellular Therapy
01
Overview
This therapeutic strategy targets tumor cells for destruction (lysis) by delivering an engineered oncolytic adenovirus using neural stem cells (NSCs) as carriers. The oncolytic adenovirus selectively replicates in and lyses tumor cells, while NSCs enhance delivery across the blood-brain barrier, improve intratumoral distribution, and protect the virus from neutralizing antibodies.
- Other names
- Oncolytic Adenovirus TherapyNSC-delivered Oncolytic VirusCRAd TherapyVirotherapy
02
Mechanism of action
Selective replication of oncolytic adenovirus within tumor cells, leading to cell lysis and release of viral particles. Neural stem cells act as carriers for targeted delivery.
03
Biological functions
Tumor cell lysisImmune stimulationViral replication
04
Disease associations
Cancer
05
Safety considerations
Off-target effectsImmune response to adenovirusManufacturing complexityIntracerebral volume limitations
Beyond the preview
Go deeper on Tumor Cell Lysis via Oncolytic Adenovirus Delivery.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tumor Cell Lysis via Oncolytic Adenovirus Delivery.